Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Demand for Innovative Therapies and Drugs
4.2.2 Increasing Research Activities Related to Genes, Proteins, and Certain Bio-molecules
4.3 Market Restraints
4.3.1 Time-consuming Technique
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Gel Electrophoresis Systems
5.1.2 Capillary Electrophoresis Systems
5.1.3 Electrophoresis Accessories
5.2 By Application
5.2.1 Academic and Research Institutes
5.2.2 Hospitals and Diagnostics Centres
5.2.3 Pharmaceutical and Biotechnology Companies
5.2.4 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bio-Rad Laboratories, Inc
6.1.2 GE Healthcare
6.1.3 Thermo Fisher Scientific Inc
6.1.4 Agilent Technologies, Inc
6.1.5 Merck Millipore (Merck & Co., Inc)
6.1.6 PerkinElmer, Inc
6.1.7 QIAGEN N.V.
6.1.8 Lonza Group Ltd
6.1.9 Shimadzu Corporation
6.1.10 Sebia Group


7 MARKET OPPORTUNITIES AND FUTURE TRENDS